Masimo (MASI) Saham Harga
Masimo Harga
Selama 19 tahun terakhir pendapatan Masimo tumbuh 10,6% per tahun, mencapai 1,53 miliar USD. Laba per saham turun 11,0% per tahun selama 17 tahun terakhir. Bagi Masimo, margin bersih sebesar -9,9% turun dibanding 18,5% beberapa tahun lalu. Pada harga saat ini imbal hasil dividen sekitar 0,56%. Rasio pembayaran sekitar 93% dari laba. Target harga konsensus 12 bulan untuk Masimo adalah 183,60 USD, sekitar di atas harga saat ini 2,0%. Dari 16 analis, 12 merekomendasikan beli — konsensus keseluruhan Beli.
Harga saham Masimo
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Masimo
Pertanyaan yang sering diajukan tentang saham Masimo
The business model of Masimo Corp focuses on providing innovative noninvasive monitoring technologies. Masimo develops and manufactures a wide range of medical devices and sensors to improve patient outcomes and reduce healthcare costs. The company's flagship product, Masimo SET®, revolutionized pulse oximetry by offering accurate measurements even in challenging conditions. With a dedication to patient safety and care, Masimo Corp combines advanced signal processing and sensor technology to deliver reliable monitoring solutions to healthcare professionals. Through their product portfolio, Masimo Corp aims to enhance patient care and promote efficiency in the healthcare industry.
Masimo Corp is primarily active in the medical device industry.
The main competitors of Masimo Corp in the market include companies such as Philips Healthcare, Nihon Kohden Corporation, and Smiths Medical.
Masimo Corp is a leading global medical technology company specializing in noninvasive patient monitoring. Founded in 1989 by Joe Kiani, the company has a rich history of innovation and advancements in the healthcare industry. Masimo Corp's core business revolves around developing and manufacturing advanced monitoring technologies, including pulse oximeters and signal extraction technology. With its commitment to improving patient outcomes and reducing healthcare costs, Masimo Corp has revolutionized the way healthcare professionals monitor patients' vital signs. Today, it is recognized as a trusted name in the medical device industry, providing innovative solutions that enhance patient care and safety worldwide.
Masimo Corp has achieved several significant milestones. Some noteworthy accomplishments include the development of breakthrough technologies in noninvasive patient monitoring, such as SET® pulse oximetry. The company has also received numerous awards and recognition for its innovative products and contributions to the healthcare industry. Masimo Corp has successfully expanded its global presence and formed strategic partnerships with leading healthcare organizations worldwide. Additionally, the company has consistently shown strong financial performance and steady revenue growth over the years. Overall, Masimo Corp continues to make strides in advancing patient care through its cutting-edge technologies and industry leadership.
Masimo Corp is primarily present in various countries and regions across the globe. Some notable markets where the company operates include the United States, European countries like Germany, France, and the United Kingdom, as well as Asian countries including Japan and China. Masimo Corp's global presence enables it to provide its innovative healthcare solutions, including noninvasive patient monitoring technologies, to healthcare facilities and professionals worldwide.
Masimo Corp represents a strong commitment to improving patient outcomes and reducing healthcare costs through innovative medical technologies. The company values include a dedication to patient safety, quality, and continuous improvement. Masimo's corporate philosophy revolves around providing noninvasive monitoring solutions that enable clinicians to make more informed decisions, enhance patient care, and optimize workflows. By combining advanced sensor and signal processing technologies, Masimo Corp strives to address the evolving needs of the medical community. The company's focus on research and development, as well as collaboration with healthcare professionals, reinforces its commitment to pioneering advancements in medical monitoring to benefit patients worldwide.
Analis saat ini menetapkan target harga rata-rata 180,21 USD untuk saham Masimo (median: 183,60 USD), yaitu +0,1 % terhadap harga terbaru. Konsensus didasarkan pada 16 peringkat analis.
15 analis saat ini menilai saham Masimo: 7 merekomendasikan beli, 8 tahan, dan 0 jual. Untuk 2026, analis memperkirakan Masimo menghasilkan pendapatan 1,63 miliar USD dan laba per saham 5,97 USD.
Dengan kurs saat ini, saham Masimo diperdagangkan pada 160,14 EUR (179,95 USD).
Saham Masimo (MASI) tercatat di 8 bursa, termasuk: NYSE (MASI), London (0JZ2.L), SIX (Zürich) (3M4.SW), Frankfurt (3M4.F), München (3M4.MU), Düsseldorf (3M4.DU).
Masimo Corporation is a leading provider of medical diagnostic and monitoring technologies that aim to make patient care safer and more effective. The company is headquartered in California and operates offices worldwide. Masimo's business model can be roughly divided into three areas: 1. Products and technologies Masimo offers a wide range of medical devices and technologies, including pulse oximeters for monitoring oxygen saturation in the blood, capnographs for monitoring end-tidal carbon dioxide concentration, as well as patient monitors and control systems. A highlight is Masimo's Signal Extraction Technology (SET), which is used in almost all of the company's products. SET uses a special algorithm to filter signals from skin color, movement, and other external sources of interference, allowing for accurate measurements. Additionally, Masimo has developed other innovative technologies, such as automatic measurement of hemoglobin levels, which can lead to improved patient outcomes. 2. Services Masimo also offers various services, such as installation, training, and technical support for its products. Furthermore, the company has entered into partnerships with other companies such as Apple and Philips to jointly develop innovative solutions for patient monitoring. 3. Research and development Masimo invests heavily in the research and development of new products and technologies. The company has filed numerous patents and successfully implemented them. By collaborating with clinics and universities, Masimo ensures that its products have informative features and high quality that meet the needs of patients and medical professionals. Overall, Masimo's business model is designed to make healthcare safer and more effective by developing innovative products and technologies, and by providing services and support to its customers. The wide range of products and technologies, as well as the investments in research and development, indicate that Masimo will continue to play an important role in the medical industry in the future.
Pendapatan diperkirakan dari Masimo adalah 1,63 miliar USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Masimo adalah 323,74 Juta. USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Masimo saat ini adalah 30,13. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Masimo.
Rasio harga-terhadap-penjualan (PSR) Masimo saat ini adalah 5,97. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Masimo.
Skor Kualitas AlleAktien untuk Masimo adalah 5/10.
ISIN dari Masimo adalah US5747951003. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Masimo adalah 578074. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Masimo adalah MASI. Simbol ticker digunakan untuk memperdagangkan saham Masimo di bursa saham.
Saham Masimo
Kelompok Peer Masimo
Masimo Ticker
Masimo FIGI
Semua metrik fundamental dan analisis mendalam Masimo
Analisis saham kami untuk saham Masimo mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Masimo. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.